Posts tagged Homeopathic.
Blogs
3 minute read
Two announcements made by FDA in late October signal a marked change to FDA’s regulatory approach to “homeopathic” drugs. On October 25, 2019, FDA withdrew the 1988 Compliance Policy Guide (“CPG”) 400.400 Conditions Under Which Homeopathic Drugs May Be Marketed, and, concurrently, published revised draft guidance titled Drug Products Labeled as Homeopathic (the “Revised Homeopathic Draft Guidance”).
Homeopathy—an alternative medical approach that began in the late 18th century—is based on the belief that (1) a substance that causes symptoms in a healthy ...
Blog Editors
Recent Updates
- OIG Limits Sign-On Bonuses to In-Home Family Caregivers
- Governing Health AI Development and Adoption: Insights from HHS’s Recently Announced Strategy to Promote AI in Healthcare
- Stranger Things: New FDA Updates Flip Expectations for the Med Tech Industry in 2026 Upside Down
- The DOJ’s Bulk Sensitive Data Rule and Your Obligation to “Know Your Vendor”
- ACCESS Model: CMMI’s New Technology-Enabled Chronic Care Model